Guru Ownership Trend
Guru Analysis for Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $47.75 M.
Top institutional holders include Larry Robbins and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $4.29 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who dramatically increased their stake. Conversely, Chuck Royce reduced exposure by 9.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Myriad Genetics, Inc. (MYGN)
Major holders include Larry Robbins ($28.21 M), Cliff Asness ($11.5 M), Steven Cohen ($7.58 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 9.93 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.29 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited MYGN. The total reported sell value was $841,984.09.
Yes, 1 managers opened new positions in MYGN, and 3 increased their existing holdings. The total reported buy value was $5.13 M.
